Indirect Treatment Comparison of Ustekinumab versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Conventional Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 709. (October 2017)